author-photo

Chan-Bum Choi

Hanyang University

147

Papers

2214

Citations

Citation Trend

Filter By

Papers (109) Sort By

Journal Conference Others

KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities

2021 Journal of Reproduction and Development
Show All
- Source
- Cite
- Save
Citations (1)
What Can Lipids in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Tell Us?

2021 Journal of Reproduction and Development
- Chan-Bum Choi
Show All
- Source
- Cite
- Save
Citations (0)
Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial

2021 Arthritis Research & Therapy
Show All
- Source
- Cite
- Save
Citations (0)
AB0370 SAFETY OF CS20AT04, A HAPLOIDENTICAL ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, IN A PHASE 1 STUDY IN LUPUS NEPHRITIS

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (6)
Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients

2019 Yonsei Medical Journal
Show All
- Source
- Cite
- Save
Citations (4)
AB1273 ESTABLISHMENT OF A PROSPECTIVE COHORT FOR RHEUMATOID ARTHRITIS PATIENTS WITH INTERSTITIAL LUNG DISEASE: COMPARISON OF BASELINE CHARACTERISTICS BETWEEN RHEUMATOID ARTHRITIS PATIENT WITH OR WITHOUT INTERSTITIAL LUNG DISEASE

2019 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review

2019 Yonsei Medical Journal
Show All
- Source
- Cite
- Save
Citations (9)
Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study

2019 Arthritis Research & Therapy
Show All
- Source
- Cite
- Save
Citations (4)
Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis

2019 Arthritis Research & Therapy
Show All
- Source
- Cite
- Save
Citations (1)